Bentonville, ARCIK 20060451 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
11 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Evommune Inc | 1.28M | $21.93M | 20.0% | +1.28M | New Position |
| 2 | Verastem Inc | 2.00M | $15.44M | 14.1% | +2.00M | New Position |
| 3 | Amplitech Group Inc | 2.56M | $13.23M | 12.1% | +2.56M | New Position |
| 4 | Precigen Inc |
| 3.00M |
| $12.54M |
| 11.5% |
| +3.00M |
| New Position |
| 5 | Inventiva SA | 2.60M | $12.09M | 11.0% | +2.60M | New Position |
| 6 | Nuvation Bio Inc | 1.25M | $11.20M | 10.2% | +1.25M | New Position |
| 7 | Rani Therapeutics Hldgs Inc | 6.30M | $8.51M | 7.8% | +6.30M | New Position |
| 8 | Aardvark Therapeutics Inc | 476.6K | $6.26M | 5.7% | +476.6K | New Position |
| 9 | Clene Inc | 770.5K | $4.52M | 4.1% | +770.5K | New Position |
| 10 | Generation Bio Co | 665.0K | $3.78M | 3.4% | +665.0K | New Position |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio